Israel’s Immunai expands strategic tie with AstraZeneca
Israeli firm Immunai, a developer of AI-based instruments for enhancing drug discovery processes, has introduced a strategic settlement with ...
Israeli firm Immunai, a developer of AI-based instruments for enhancing drug discovery processes, has introduced a strategic settlement with ...